Ireland - English - HPRA (Health Products Regulatory Authority)

imbat limited - fexofenadine hydrochloride - film-coated tablet - 180 milligram(s) - other antihistamines for systemic use; fexofenadine

Ireland - English - HPRA (Health Products Regulatory Authority)

pco manufacturing ltd. - fexofenadine hydrochloride - film-coated tablet - 180 milligram(s) - other antihistamines for systemic use; fexofenadine

Ireland - English - HPRA (Health Products Regulatory Authority)

lexon (uk) ltd - fexofenadine hydrochloride - film-coated tablet - 180 milligram(s) - other antihistamines for systemic use; fexofenadine

Ireland - English - HPRA (Health Products Regulatory Authority)

opella healthcare france sas t/a sanofi - fexofenadine hydrochloride - film-coated tablet - 180 milligram(s) - other antihistamines for systemic use; fexofenadine

Ireland - English - HPRA (Health Products Regulatory Authority)

ltt pharma limited - fexofenadine hydrochloride - film coated tablet - 180 milligram - other antihistamines for systemic use

Malta - English - Medicines Authority

opella healthcare france sas t/a sanofi 157 avenue charles de gaulle, 92200 neuilly-sur-seine , france - fexofenadine hydrochloride - film-coated tablet - fexofenadine hydrochloride 180 mg - antihistamines for systemic use

Malta - English - Medicines Authority

sanofi s.r.l viale l. bodio, 37/b 20158, milan, italy - fexofenadine hydrochloride - film-coated tablet - fexofenadine hydrochloride 180 milligram(s) - antihistamines for systemic use

Malta - English - Medicines Authority

sanofi malta limited - fexofenadine hydrochloride - film-coated tablet - fexofenadine hydrochloride 180 mg - antihistamines for systemic use

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - fexofenadine hydrochloride, quantity: 6 mg/ml - oral liquid, suspension - excipient ingredients: poloxamer; xylitol; sucrose; propylene glycol; monobasic sodium phosphate monohydrate; propyl hydroxybenzoate; disodium edetate; purified water; butyl hydroxybenzoate; dibasic sodium phosphate heptahydrate; xanthan gum; titanium dioxide; flavour - relief of symptoms associated with seasonal allergic rhinitis and allergic rhinitis in adults and children from 2 years of age. relief of symptoms associated with urticaria in adults and children from 6 months of age.

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - fexofenadine hydrochloride, quantity: 30 mg - tablet, film coated - excipient ingredients: titanium dioxide; pregelatinised maize starch; hypromellose; macrogol 400; colloidal anhydrous silica; magnesium stearate; povidone; microcrystalline cellulose; croscarmellose sodium; iron oxide red; iron oxide yellow - relief of symptoms associated with seasonal allergic rhinitis, allergic rhinitis or urticaria in adults and children from 6 years of age.